Frequency Accounts Payable vs Short Term Investments Analysis
| KRRO Stock | 52.31 1.69 3.34% |
Frequency Therapeutics financial indicator trend analysis is much more than just examining Frequency Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Frequency Therapeutics is a good investment. Please check the relationship between Frequency Therapeutics Accounts Payable and its Short Term Investments accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.
Accounts Payable vs Short Term Investments
Accounts Payable vs Short Term Investments Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Frequency Therapeutics Accounts Payable account and Short Term Investments. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Frequency Therapeutics' Accounts Payable and Short Term Investments is -0.47. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Frequency Therapeutics, assuming nothing else is changed. The correlation between historical values of Frequency Therapeutics' Accounts Payable and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Frequency Therapeutics are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Accounts Payable i.e., Frequency Therapeutics' Accounts Payable and Short Term Investments go up and down completely randomly.
Correlation Coefficient | -0.47 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Accounts Payable
An accounting item on the balance sheet that represents Frequency Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Frequency Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Short Term Investments
Short Term Investments is an item under the current assets section of Frequency Therapeutics balance sheet. It contains any investments Frequency Therapeutics undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Frequency Therapeutics can easily liquidate in the marketplace.Most indicators from Frequency Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Frequency Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.At this time, Frequency Therapeutics' Enterprise Value Over EBITDA is very stable compared to the past year. As of the 25th of November 2024, Enterprise Value Multiple is likely to grow to 0.75, while Tax Provision is likely to drop about 14.3 K.
| 2023 | 2024 (projected) | Interest Expense | 106.2K | 106.1K | Depreciation And Amortization | 3.6M | 2.1M |
Frequency Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Frequency Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Frequency Therapeutics fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 223.2M | 264.7M | 127.6M | 73.7M | 221.7M | 153.3M | |
| Other Current Liab | 3.4M | 6.7M | 4.2M | 3.2M | 10.2M | 10.7M | |
| Total Current Liabilities | 52.8M | 26.6M | 4.9M | 8.7M | 19.5M | 18.6M | |
| Total Stockholder Equity | 167.4M | 192.5M | (42.2M) | (99.0M) | 169.9M | 178.4M | |
| Property Plant And Equipment Net | 1.8M | 37.8M | 7.1M | 11.9M | 42.8M | 45.0M | |
| Net Debt | (200.2M) | (174.3M) | (37.9M) | (33.2M) | (132.9M) | (126.3M) | |
| Retained Earnings | (68.9M) | (95.4M) | (43.8M) | (101.8M) | (183.0M) | (173.9M) | |
| Accounts Payable | 1.2M | 5.5M | 789K | 2.6M | 7.3M | 7.6M | |
| Cash | 200.2M | 220.3M | 83.5M | 36.3M | 166.2M | 120.5M | |
| Non Current Assets Total | 1.9M | 39.7M | 7.8M | 16.7M | 48.9M | 51.4M | |
| Non Currrent Assets Other | 101.0K | (1.0) | (12.8M) | 228K | 2.7M | 2.8M | |
| Cash And Short Term Investments | 217.4M | 220.3M | 118.5M | 55.2M | 166.2M | 131.6M | |
| Common Stock Shares Outstanding | 616.9K | 645.1K | 4.4M | 255.2K | 1.5M | 1.4M | |
| Liabilities And Stockholders Equity | 223.2M | 264.7M | 127.6M | 73.7M | 221.7M | 153.3M | |
| Non Current Liabilities Total | 3.1M | 45.6M | 164.8M | 164.1M | 32.3M | 30.7M | |
| Other Current Assets | 3.2M | 4.4M | 1.2M | 1.8M | 6.6M | 6.9M | |
| Other Stockholder Equity | 236.2M | 287.8M | 1.6M | 2.8M | 352.9M | 370.6M | |
| Total Liab | 55.9M | 72.2M | 169.8M | 172.8M | 51.8M | 49.2M | |
| Total Current Assets | 221.4M | 225.1M | 119.8M | 57.1M | 172.7M | 134.7M | |
| Common Stock | 14K | 31K | 34K | 5K | 8K | 7.2K |
Pair Trading with Frequency Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Frequency Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Frequency Stock
| 0.67 | MTEM | Molecular Templates | PairCorr |
| 0.58 | ME | 23Andme Holding | PairCorr |
| 0.57 | TPST | Tempest Therapeutics | PairCorr |
| 0.53 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.5 | A | Agilent Technologies Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Frequency Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Frequency Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Frequency Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Frequency Therapeutics to buy it.
The correlation of Frequency Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Frequency Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Frequency Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Frequency Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Frequency Therapeutics. If investors know Frequency will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Frequency Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.42) | Return On Assets (0.35) | Return On Equity (0.75) |
The market value of Frequency Therapeutics is measured differently than its book value, which is the value of Frequency that is recorded on the company's balance sheet. Investors also form their own opinion of Frequency Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Frequency Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Frequency Therapeutics' market value can be influenced by many factors that don't directly affect Frequency Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Frequency Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Frequency Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Frequency Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.